SO-YOUNG INTERNATIONAL INC. - AMERICAN DEPOSITORY

HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers

10 Apr 2021 07:31:00 By Nasdaq GlobeNewswire

So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2020 Financial Results

22 Mar 2021 04:10:00 By Nasdaq GlobeNewswire

HOOKIPA Reports Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Outlook

18 Mar 2021 06:00:01 By Nasdaq GlobeNewswire

So-Young to Report Fourth Quarter and Full Year 2020 Financial Results on March 22, 2021

12 Mar 2021 04:30:00 By Nasdaq GlobeNewswire

HOOKIPA Pharma To Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, March 18, 2021

09 Mar 2021 06:00:00 By Nasdaq GlobeNewswire

Pre-clinical data on HOOKIPA’s alternating 2-vector cancer therapeutics published in Cell Reports Medicine

04 Mar 2021 06:00:01 By Nasdaq GlobeNewswire

HOOKIPA Pharma to Participate in Upcoming H.C. Wainwright Global Life Sciences Conference

03 Mar 2021 06:00:00 By Nasdaq GlobeNewswire

HOOKIPA Pharma to Participate in Upcoming SVB Leerink Global Healthcare Conference

16 Feb 2021 06:00:01 By Nasdaq GlobeNewswire